[CLINICAL TRIALS OF A METHYLHYDRAZINE DERIVATIVE AND ITS COMBINATION WITH TELECOBALT THERAPY].
D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D004358:Drug Therapy; D004938:Esophageal Neoplasms; D005260:Female; D006689:Hodgkin Disease; D006801:Humans; D006834:Hydrazines; D007822:Laryngeal Neoplasms; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008763:Methylhydrazines; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D010610:Pharyngeal Neoplasms; D011867:Radioisotope Teletherapy; D012509:Sarcoma; D002583:Uterine Cervical Neoplasms
D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D006834:Hydrazines; D008763:Methylhydrazines
ANTINEOPLASTIC AGENTS; CERVIX NEOPLASMS; COBALT ISOTOPES; DRUG THERAPY; ESOPHAGEAL NEOPLASMS; HODGKIN'S DISEASE; HYDRAZINES; LARYNGEAL NEOPLASMS; LYMPHOSARCOMA; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; PHARYNGEAL NEOPLASMS; RADIOISOTOPE TELETHERAPY; SARCOMA, RETICULUM CELL
ESSAIS CLINIQUES D'UN DERIVE DE LA METHYL-HYDRAZINE ET DE SON ASSOCIATION AVEC LA TELECOBALTHERAPIE.